-
Mashup Score: 4How a genetically compatible stem cell donor could be key to a Pennsylvania mother's future - 1 year(s) ago
Ethnic groups have genetic similarities which increases the odds of finding a stem cell match. It’s a connection a 44-year-old Vivian Chang Larson is hoping to find.
Source: www.cbsnews.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 3Chimerically Speaking: Episode 5 - Transplant Strikes Back... immediately! The ASAP trial takes on active disease on Apple Podcasts - 1 year(s) ago
Show Chimerically Speaking, Ep Episode 5 – Transplant Strikes Back… immediately! The ASAP trial takes on active disease – May 28, 2024
Source: podcasts.apple.comCategories: General Medicine News, Hem/OncsTweet-
RT @ChimeraSpeaking: Don't miss! Apple: https://t.co/VccXL2GeuU Spotify: https://t.co/msWPs6W47f @Haemophage @joshuaafein @moh7madhomod htt…
-
-
Mashup Score: 20The Bone-Marrow Transplant Revolution - 1 year(s) ago
Finding a matched donor has always been the major challenge. A drug has solved that problem.
Source: www.theatlantic.comCategories: General Medicine News, Hem/OncsTweet-
Some sobering numbers “ Two-thirds of white people can find a fully matched registry donor, but that number drops to 23 percent for Black Americans and 41 percent for Asians or Pacific Islanders We need more donors to join @CanadasLifeline #bmtsm https://t.co/oXepkiezRG
-
-
Mashup Score: 19The Bone-Marrow Transplant Revolution - 1 year(s) ago
Finding a matched donor has always been the major challenge. A drug has solved that problem.
Source: www.theatlantic.comCategories: General Medicine News, Hem/OncsTweet-
Some sobering numbers “ Two-thirds of white people can find a fully matched registry donor, but that number drops to 23 percent for Black Americans and 41 percent for Asians or Pacific Islanders We need more donors to join @CanadasLifeline #bmtsm https://t.co/oXepkiezRG
-
-
Mashup Score: 17The Bone-Marrow Transplant Revolution - 1 year(s) ago
Finding a matched donor has always been the major challenge. A drug has solved that problem.
Source: www.theatlantic.comCategories: General Medicine News, Hem/OncsTweet-
Some sobering numbers “ Two-thirds of white people can find a fully matched registry donor, but that number drops to 23 percent for Black Americans and 41 percent for Asians or Pacific Islanders We need more donors to join @CanadasLifeline #bmtsm https://t.co/oXepkiezRG
-
-
Mashup Score: 20The Survivor: Zach Colton needed a five-organ transplant. He waited 16 years to increase the odds of survival to a coin toss - 1 year(s) ago
A rare genetic condition virtually shut down Zach Colton’s digestive system. He survived for years without eating for a chance to live again
Source: ottawacitizen.comCategories: General Medicine News, Hem/OncsTweet-
Five organs transplanted in a single surgery! I know Transplant Surgeons are hardcore but this is incredible! 🤯🤯🤯 @UHNTransplant https://t.co/04vBa4XvFu
-
-
Mashup Score: 3Outcomes of therapy‐related acute lymphoblastic leukemia in adults after allogeneic stem cell transplantation - 1 year(s) ago
Introduction Therapy-related acute lymphoblastic leukemia (t-ALL) is an increasingly recognized subset of therapy-related acute leukemia. There are limited data on the role of allogeneic hematopoiet…
Source: onlinelibrary.wiley.comCategories: General Medicine News, Hem/OncsTweet-
@sghmd @BMTjunkie @RoswellPark Shameless plug for our paper on therapy related ALL by @iamramvn https://t.co/wCAI8O3IA3
-
-
Mashup Score: 1Allogeneic Stem Cell Transplant Clinic - 2 year(s) ago
Allogeneic blood and marrow transplants treat conditions such as cancers of the blood and bone marrow.
Source: www.uhn.caCategories: General Medicine News, Hem/OncsTweet-
RT @Hans_BMTProgram: Pictures courtesy of Dr. Messner’s family. For more information, please visit https://t.co/eqWZp1FBZk To support the…
-
-
Mashup Score: 3
The combination of adriamycin, bleomycin, vinblastine, and dacarbazine (ABVD) has been the standard of care for frontline treatment of classical Hodgkin lymphoma (cHL) for more than 20 years [1,2]. Efforts to improve risk stratification and outcomes have led to the use of fluorodeoxyglucose-positron emission tomography (PET)-guided therapy following initial treatment with ABVD, in which treatment intensity is reduced or intensified based on metabolic disease response [3,4]. Despite excellent results with this approach, approximately 30% of patients with cHL will be refractory to frontline therapy or experience relapse [3–5].
Source: www.astctjournal.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
@nihardesai7 @BijoyTelivala @PallawiTorkaMD @AaronGoodman33 @MediHumdani @OncBrothers @majorajay @Eddie_Cliff @hardikstweet Usually reserved for patients that progress after Auto but personally feel that it should be offered earlier @olivier76409488 showed here that the duration of remission is very short so there is a narrow window of opportunity. https://t.co/BRgNStOJP3
-
-
Mashup Score: 1
Allogeneic hematopoietic cell transplantation (HCT) offers cure for some patients with hematological diseases but is associated with significant risk of morbidity and mortality. We investigated the incidence of AKI and its impact on transplant outcomes among 408 patients transplanted at Princess Mar …
Source: pubmed.ncbi.nlm.nih.govCategories: Hem/Oncs, Latest HeadlinesTweet-
@nihardesai7 @Prasshmehta @Mohty_EBMT @romeerizwan @RahulDoc2 @DrGKharya @DrGPrakash We’ve had consistent success with FB2TBI(200) at @pmcancercentre Pathogenesis of AKI is multifactorial, as shown in our paper by @kaylamadsen2 https://t.co/LfLCc7P0nc
-
RT @nmdp_org: Vivian is searching for a life-saving match and she needs your help! 💙 Check out her story here: https://t.co/cBjfpMC6Ev